"What we have seen is that adult stem cells cultured from the bone marrow of humans, mice and rats can be induced to differentiate into cells that look, stain and function like liver cells," said Catherine Verfaillie, M.D., director of the University of Minnesota Stem Cell Institute and author of the research. "Our lab shows, for the first time, clear indication that these stem cells function like liver cells in that they secreted three key elements: albumin, the most abundant protein made by the liver; urea, produced only by liver and kidney epithelium; and cytochrome P450, the major detoxifying enzyme in the liver."
According to Verfaillie, the benefits of the research could be broad.
"These adult stem cells are indeed a good source of cells for patients with genetic diseases of the liver, such as alpha 1 antitrypsin deficiency, which affects 100,000 in the United States," she said. "It may also be helpful for some types of cirrhosis or acute liver failure due to medications. In addition, the cells might be used to create bio-artificial livers and replace the use of pig liver cells, which are a commonly used source of cells now. Much as dialysis machines can be a bridge for patients waiting for kidneys, a bio-artificial liver can help bridge a person from acute liver failure to transplant.
"The immediate benefit might well be to help pharmaceutical researchers and manufacturers screen for toxicity and efficiency of drugs prior to phase I clinical trials."
Verfaillie and her colleagues announced late last year that these cells, called multipotent adult progenitor cells (MAPCs), demonstrate the potential to differentiate beyond mesenchymal cells, into cells of visceral mesodermal origin, such as endothelium, as well as into cells with neuroectodermal phenotype and function.
The objective of the Stem Cell Institute is to further our understanding of the potential of stem cells to improve human and animal health. The SCI is a part of the University of Minnesota's Academic Health Center and is an interdisciplinary center with member faculty representing a diverse group of university schools, colleges and centers. For online information about the Stem Cell Institute, go to www1.umn.edu/stemcell.
Embargoed by the Journal of Clinical Investigation until 12:01 a.m. Wednesday, May 15
Catherine Verfaillie, M.D., director, University of Minnesota Stem Cell Institute
Sarah Youngerman, Academic Health Center communications, (612) 624-4604, email@example.com